Quantib Brain

Quantib™ Brain 1.3 is a medical image processing software designed to automatically segment and quantify brain structures (GM, WM, CSF, WMH) from MR images using atlas-based algorithms and a classifier for WMH, functioning as a post-processing plugin for GE workstations. The underlying science involves advanced image segmentation techniques, including a revised voting mechanism for intracranial volume and an improved classifier with an extended feature set for white matter hyperintensity detection, validated against manual segmentations using metrics like the Dice index.

Quantib™ Brain 1.3 is a non-invasive medical imaging processing application designed for the automatic labeling, visualization, and volumetric quantification of segmentable brain structures from magnetic resonance (MR) images. It processes 3D T1-weighted MR images, with an additional T2-weighted FLAIR MR image for white matter hyperintensity (WMH) segmentation, to provide quantitative measurements of grey matter (GM), white matter (WM), cerebrospinal fluid (CSF), and WMH candidates. The software functions as a post-processing plugin for GE Advantage Workstation or AW Server platforms, intended to offer trained medical professionals complementary information for evaluating MR brain images and aiding in quantitative reporting. Users are required to review and, if necessary, edit the automatically identified WMH candidates before their validation. The device employs an atlas-based segmentation system, where each atlas consists of a 3D T1-weighted MR image and a corresponding label map. Version 1.3 introduced modifications including a different voting mechanism to improve intracranial volume (ICV) results and an updated WMH segmentation algorithm using a different classifier with an extended set of features. Performance validation against manual segmentations on test datasets yielded Dice index scores of 0.78 for CSF, 0.84 for GM, 0.86 for WM, 0.97 for ICV, and 0.61 for WMHs. The software also supports longitudinal analysis for brain tissue and WMH segmentation to compare multiple exams from an individual patient, although certain volumetric measures are not reported when contrast-enhanced 3DT1w scans are used for WMH processing.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the performance of the WMH segmentation algorithm, with a Dice index of 0.61 ± 0.13, compare to other contemporary automated methods, and what are the clinical implications of this level of accuracy for patient assessment?; What specific atlases are utilized by Quantib™ Brain 1.3 for segmentation, and how does their diversity or specificity impact the algorithm's robustness across different patient demographics and MR scanner vendors?; The document mentions that version 1.3 extended the set of features for the WMH classifier; could you elaborate on the nature of these new features and their individual contributions to the improved algorithm performance?; Given that users must review and potentially edit WMH candidates, what is the estimated typical time burden associated with this manual review process, and how does this user interaction affect overall clinical workflow efficiency?; How does the Quantib™ Brain software handle variability in MR image quality, such as motion artifacts or differing signal-to-noise ratios, and are there specific input image acquisition parameters recommended to ensure optimal segmentation performance?